Cancer immunotherapy represents a promising targeted treatment by leveraging the
patient's immune system or adoptive transfer of active immune cells to selectively eliminate …

Chemotherapy and surgery remain the primary treatment modalities for cancers; however,
these techniques have drawbacks, such as cancer recurrence and toxic side effects …

RNA interference (RNAi) therapeutics are an emerging class of medicines that selectively
target mRNA transcripts to silence protein production and combat disease. Despite the …

Glioblastoma is characterized by diffuse infiltration into surrounding healthy brain tissues,
which makes it challenging to treat. Complete surgical resection is often impossible, and …

Liposomes can greatly improve the pharmacokinetics of therapeutic agents due to their
ability to encapsulate drugs and accumulate in target tissues. Considerable effort has been …

The delivery of lipid nanoparticle (LNP)-based mRNA therapeutics has captured the
attention of the vaccine research community as an innovative and versatile tool for treating a …

Cancer immunotherapy offers transformative promise particularly for the treatment of lethal
cancers, since a correctly trained immune system can comprehensively orchestrate tumor …

Immunomodulation is a powerful therapeutic approach that harnesses the body's own
immune system and reprograms it to treat diseases, such as cancer. Innate immunity is key …

Cold tumors lack antitumor immunity and are resistant to therapy, representing a major
challenge in cancer medicine. Because of the immunosuppressive spirit of the tumor …

Nanoparticles have the potential to improve disease treatment and diagnosis due to their
ability to incorporate drugs, alter pharmacokinetics, and enable tissue targeting. While …